I, on behalf of Journal of Pharmacy and Bioallied Sciences (JPBS) editorial and technical team extend heartfelt New Year Greetings to all our readers and contributors. Without the ardent untiring contribution of JPBS team, the first issue of 2016 seems to be impossible. A bird\'s eye view of past 2015 speaks volume of JBPS credibility for publishing quality papers from all around the globe. With more than 400 manuscripts submitted round the year, the journal maintained a steady statistics of acceptance, i.e., \<20%. JPBS also sponsored the seminar "Regulatory and Quality Aspects of Herbal Drugs and Botanicals" and published selected articles as 2015 special issue along with dental supplement issue. The robust intellectual support and well-timed contribution of reviewers deserve special appreciatory applause. Our team expects similar sort of sincere dedication from the reviewers in near future.

The current issue of January-March 2016 is again reflective of journal\'s internationally acclaimed status with articles from Malaysia, Iran, Japan, Australia, Ethiopia, KSA, Nigeria, and as well as encompassing exploratory and explanatory full blown research from the disciplines of pharmaceutical technology, pharmacology, pharmacognosy, pharmacy practice, and clinical pharmacy. Review article contributions in diverse areas such as forensic pharmacology, Marine pharmacology, cardiovascular medicines, and short communication in renal pharmacology open up new horizons of future research in basic disciplines and clinical practice. Significant new messages and comments on prior published articles in the form of letters to editors in nanotechnology, personalized medicine, and complementary and alternative medicine highlight the interest of the contributors toward minute details in research.

We sincerely wish that the New Year will unfold new publication avenues in JPBS encompassing research works focusing more extensively on vaccine development, marketing and utilization, prevention strategies for noncommunicable diseases, and emerging diseases research. We expect future submissions in areas of reproducibility and reliability of biomedical research, mixed method research in pharmacy practice and clinical pharmacy, safety requirements, and legislations and labeling regulations in cosmeceuticals, and electronic cigarettes, and emerging role of pharmacists such as relief pharmacists, domiciliary pharmacists, and immunization pharmacists. Papers on interdisciplinary collaborations with animal and human health researchers in areas of emerging diseases such as Ebola and Zika with an outcome-based approach will be awaited.
